Alpha 2.0
Login Register
» Articles » PMID: 6097171

Susceptibility of Bordetella Pertussis to Cephalosporin Derivatives and Imipenem

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1984 Oct 1
PMID 6097171
Citations 9
Authors
R M Bannatyne
R Cheung
Affiliations
Soon will be listed here.
Abstract

The in vitro activities of 16 cephalosporin derivatives and imipenem against 60 strains of Bordetella pertussis were examined. Cefoperazone, imipenem, and ceftriaxone were the most active, with MICs that inhibited 90% of the strains of 0.006, 0.05, and 0.1 microgram/ml, respectively. Cephalexin, cephradine, and cefsulodin were the least active, with MICs of 25 to 125 micrograms/ml. The remainder of the agents demonstrated intermediate activity.

Citing Articles

Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Hoppe J, Tschirner T Eur J Clin Microbiol Infect Dis. 1995; 14(9):775-9.

PMID: 8536725 DOI: 10.1007/BF01690992.

Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Kearns G, Young R Clin Pharmacokinet. 1994; 26(3):169-89.

PMID: 8194281 DOI: 10.2165/00003088-199426030-00002.

Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Richards D, Heel R Drugs. 1985; 29(4):281-329.

PMID: 3888599 DOI: 10.2165/00003495-198529040-00001.

Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Clissold S, Todd P Drugs. 1987; 33(3):183-241.

PMID: 3552595 DOI: 10.2165/00003495-198733030-00001.

Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Brogden R, Ward A Drugs. 1988; 35(6):604-45.

PMID: 3048974 DOI: 10.2165/00003495-198835060-00002.

References
1.
STAINER D, Scholte M . A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970; 63(2):211-20. DOI: 10.1099/00221287-63-2-211. View
2.
Neu H . The new beta-lactamase-stable cephalosporins. Ann Intern Med. 1982; 97(3):408-19. DOI: 10.7326/0003-4819-97-3-408. View
3.
Regan J, Lowe F . Enrichment medium for the isolation of Bordetella. J Clin Microbiol. 1977; 6(3):303-9. PMC: 274757. DOI: 10.1128/jcm.6.3.303-309.1977. View
4.
Sutcliffe E, Abbott J . Selective medium for the isolation of bordetella pertussis and parapertussis. J Clin Pathol. 1972; 25(8):732-3. PMC: 477490. DOI: 10.1136/jcp.25.8.732. View